GUSTAFSON MARK 4
4 · Alzamend Neuro, Inc. · Filed Dec 16, 2021
Insider Transaction Report
Form 4
GUSTAFSON MARK
Director
Transactions
- Sale
Common Stock
2021-12-14$2.85/sh−20,000$57,086→ 30,000 total
Footnotes (1)
- [F1]The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.8543. The range of sale prices on the transaction date was $2.85 to $2.87 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price